Balasabas, Cristina .
HRN: 24-70-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/22/2024
03/29/2024
IV
600mg
Q6
Septic Shock Sec To CAP-HR
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes